Inspire Medical Systems Reports Q3 2026 Results with Revenue Growth Ahead of Expectations
Inspire Medical Systems (INSP) reported third-quarter results that exceeded internal expectations for both revenue and adjusted operating income. The company achieved a 3% sequential increase in revenue and maintained strong operating cash flow during the period. Despite the positive quarterly performance, management provided a cautious outlook regarding long-term growth, projecting low single-digit revenue growth through 2027 as the coding environment for their procedures stabilizes. This guidance suggests a transition period for the company's reimbursement landscape.
Tickers: $INSP
Topics: cash flow earnings report operating income revenue growth